The RASopathies: from pathogenetics to therapeutics
The RASopathies are a group of disorders caused by a germline mutation in one of the genes encoding a component of the RAS/MAPK pathway. These disorders, including neurofibromatosis type 1, Noonan syndrome, cardiofaciocutaneous syndrome, Costello syndrome and Legius syndrome, among others, have over...
Main Authors: | Katie E. Hebron, Edjay Ralph Hernandez, Marielle E. Yohe |
---|---|
Format: | Article |
Language: | English |
Published: |
The Company of Biologists
2022-02-01
|
Series: | Disease Models & Mechanisms |
Subjects: | |
Online Access: | http://dmm.biologists.org/content/15/2/dmm049107 |
Similar Items
-
Cardiofaciocutaneous Syndrome: Case Report of a Rare Disorder
by: Soutrik Seth, et al.
Published: (2016-11-01) -
Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1
by: Leora Witkowski, et al.
Published: (2020-04-01) -
Genetic testing for lymphedema in RASopathies
by: Paolacci Stefano, et al.
Published: (2018-09-01) -
MEK-inhibitor-mediated rescue of skeletal myopathy caused by activating Hras mutation in a Costello syndrome mouse model
by: William E. Tidyman, et al.
Published: (2022-02-01) -
Integrated in silico MS-based phosphoproteomics and network enrichment analysis of RASopathy proteins
by: Javier-Fernando Montero-Bullón, et al.
Published: (2021-07-01)